Key predictors of non-interventional mitral regurgitation improvement: Insights from the SHEBAHEART registry

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

About the speaker

Doctor Shir Elimeleh

Sheba Medical Center, Ramat Gan (Israel)

7 More presentations in this session

Presentation thumbnail

Discussant - Treatment and outcome of mitral valve regurgitation

Presentation thumbnail

Concomitant mitral regurgitation is associated with worse outcomes after T-TEER: insights from the EuroTR registry

Doctor D. Felbel (Ulm, DE)

Presentation thumbnail

Echocardiographic insights: factors influencing mitral regurgitation in fabry disease

Doctor A. Vecerova (Prague, CZ)

Presentation thumbnail

The role of NT ProBNP and Galectin 3 in the follow up of patients with primary mitral regurgitation

Doctor C. Riebel (Cluj Napoca, RO)

Presentation thumbnail

Granger causality analysis of factors driving atrial functional mitral regurgitation in atrial fibrillation

Doctor T. Avram (Cluj Napoca, RO)

Access the full session

Session thumbnail

New perspectives in cardiology (3) - Treatment and outcome of mitral valve regurgitation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

The power of optimal medical therapy in heart failure with secondary mitral regurgitation

Congress Presentation

Improvement of mitral regurgitation following transcatheter aortic valve implantation: outcomes and predictors in a retrospective cohort study

Congress Presentation

Post-procedural mitral regurgitation as an independent predictor of morbidity and mortality outcomes

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources